Atherogenesis and metabolic dysregulation in LDL receptor-knockout rats

JCI Insight
|May 5, 2017
PubMed

Insights

Genetically engineered rats lacking the LDL receptor (Ldlr) develop obesity and insulin resistance. These Ldlr-knockout rats also develop significant atherosclerotic lesions, offering a new model for studying cardiovascular disease.

Area of Science:

  • Cardiovascular Research
  • Metabolic Disease Research
  • Animal Models

Background:

  • Atherosclerosis research relies heavily on genetically engineered mice, but other models are scarce.
  • Standard rodent models show limited atherosclerotic lesion development, even with high-fat diets.

Purpose of the Study:

  • To investigate the impact of LDL receptor (Ldlr) deletion on lipoprotein metabolism and atherosclerosis in Sprague-Dawley rats.
  • To establish a novel rat model for studying obesity, insulin resistance, and atherosclerosis.

Main Methods:

  • Generated LDL receptor knockout (Ldlr-KO) Sprague-Dawley rats.
  • Administered normal chow or Western diet.
  • Monitored weight gain, glucose intolerance, plasma lipids, PCSK9, leptin, and adiponectin.
  • Assessed atherosclerotic lesion development in the aorta.

Main Results:

  • Ldlr-KO rats exhibited increased plasma total cholesterol and triglycerides, obesity, and glucose intolerance compared to wild-type (WT) rats.
  • KO rats showed elevated PCSK9 and leptin, and reduced adiponectin levels.
  • Significant atherosclerotic lesions developed in the aortic arch and abdominal aorta of KO rats after 34-52 weeks on a Western diet.

Conclusions:

  • Ldlr-KO rats represent a valuable new model for studying diet-induced obesity, insulin resistance, and atherosclerosis.
  • This model provides a platform for investigating the mechanisms underlying these interconnected conditions.